Ascendis Pharma A/S 2022 SR
The report outlines Ascendis Pharma's 2022 sustainability activities, introducing a new Patients|Environmental, Social, and Governance (P|ESG) framework. Key highlights include the launch of an Expanded Access Program for TransCon PTH, the initiation of GHG Scope 1 and 2 data collection, and maintaining equal gender representation across all management levels. The company also updated its Code of Business Conduct & Ethics and established a global sustainability steering group. Future ambitions for 2023 focus on conducting impact, risk, and opportunity assessments to align with global standards and regulations.
Company: Ascendis Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2022
Type: SR
Pages: 25
Back to company
Ascendis Pharma A/S
Sustainability And P|ESG Report
The report outlines Ascendis Pharma's 2022 sustainability activities, introducing a new Patients|Environmental, Social, and Governance (P|ESG) framework. Key highlights include the launch of an Expanded Access Program for TransCon PTH, the initiation of GHG Scope 1 and 2 data collection, and maintaining equal gender representation across all management levels. The company also updated its Code of Business Conduct & Ethics and established a global sustainability steering group. Future ambitions for 2023 focus on conducting impact, risk, and opportunity assessments to align with global standards and regulations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
May 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees